Other
Metabolism
0
Pipeline Programs↗
32
Active Trials↗
38
Companies Involved↗
Metabolism is an early-stage landscape with 0 programs across 38 companies. The most active players are Bristol-Myers Squibb, Boehringer Ingelheim, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
301
clinical trials
Completed223 · 74%
Unknown status26 · 9%
Recruiting17 · 6%
Withdrawn9 · 3%
Active, not recruiting9 · 3%
Terminated8 · 3%
Other9 · 3%
Clinical Trials
Trial Activity
301 trials
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT01803451·80 enrolled
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Recruiting·—·Phase 2·NCT06041789·45 enrolled
The Effects of Bariatric Surgeries on Glucose Metabolism
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT02823665·200 enrolled
Page 1 of 21
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)